Lipoprotein-regulating medicaments
US6344441B1 · kind B1 · utility
25Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2000 |
| Grant date | Feb 5, 2002 |
| Priority date | — |
| Expiry date | Feb 4, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions useful for modulating lipoprotein levels in vivo. The invention stems from the discovery that activity of the Lipolysis Stimulated Receptor (LSR) can be inhibited or enhanced by exogenous agents, including polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.